Injective vs THORChain Staking
Side-by-side comparison of INJ and RUNE staking yields, risk, and key metrics. Updated every 4 hours.
Detailed comparison
Injective vs THORChain: which should you stake?
THORChain currently offers the higher APY at 8.00% compared to Injective's 6.39%. That's a 1.61 percentage point difference in annual yield.
In terms of market cap, Injective is the larger asset at $299.30M, which generally indicates more liquidity and lower volatility risk.
Both assets can be staked through various platforms and protocols. Consider diversifying across both rather than choosing one exclusively — this spreads your risk across different networks and ecosystems.
Injective vs THORChain — common questions
Is Injective or THORChain better for staking?
THORChain currently offers a higher staking APY at 8.00% compared to Injective's 6.39%. However, the best choice depends on your risk tolerance, investment horizon, and portfolio strategy.
What is the APY difference between Injective and THORChain?
Injective offers 6.39% APY while THORChain offers 8.00% APY — a difference of 1.61 percentage points.
Which is safer to stake: INJ or RUNE?
Injective has a medium risk rating while THORChain has a medium risk rating. Lower risk typically means a more established network with stronger validator infrastructure.
Can I stake both INJ and RUNE?
Yes, diversifying across multiple staking assets is a common strategy. Staking both Injective and THORChain spreads your risk across different networks and protocols.